Pausing breast cancer treatment for pregnancy appears safe
Young women diagnosed with breast cancer often must delay pregnancy for years while they take…
Category: cancer
Cancer patients endure an overlooked financial burden: hospital parking fees
For many patients, one of the most antagonizing parts of a hospital visit is paying…
STAT+: In ‘landmark’ study, cell therapy exceeds expectations in melanoma patients
When tumors like melanoma form, the immune system mobilizes for war. White blood cells called…
‘I question what I know’: Top cancer specialist Otis Brawley on valuing orthodoxy in medicine
Oncologist Otis Brawley has dedicated his career to advocating for orthodoxy in medicine. Now, he…
STAT+: FDA scolds company that raised red flags over impurities in many widely used medicines
Two years after an independent laboratory began pushing the U.S. Food and Drug Administration to…
STATUS List Spotlight: A Conversation with Otis Brawley
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. This February,…
STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination study
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy…
STAT+: A year after petition, NIH reviews request to lower cancer drug’s cost by sidestepping patents
One year after being asked to widen access to a pricey cancer treatment by using…
Opinion: Better lab test standards can ensure precision medicine is truly precise
Cancer is becoming less deadly in America. According to the recently released Annual Report to…
STAT+: mRNA startup Strand Therapeutics raises millions to test targeted cancer therapies
When Jacob Becraft addressed a bustling party of a hundred-plus employees, friends, and investors at…
Q&A: Siddhartha Mukherjee on the rapid pace of cancer research and ‘luminous’ life of cells
The first cells Siddhartha Mukherjee ever saw were T cells, pulled from a mouse spleen…
Healthier Ingredient Swaps
Eating healthier may seem overwhelming, but it shouldn’t be! It can be as simple as…
Spotlight on Supplements: Shark Cartilage
Globally, the continued increase of the bone and joint supplement market is attributed to our…
To Juice or Not to Juice?
Juicing is on the fast track from fad to full-on health craze. Thanks to an…
STAT+: GSK to withdraw blood cancer drug from U.S. market following confirmatory study setback
British pharma giant GSK said Tuesday that it will withdraw its blood cancer drug Blenrep…
Get Relief from Heartburn and Acid Reflux
Most people experience occasional heartburn from time to time, but when that burning sensation in…
Ask Tufts Experts: Washing Organic Foods; Instant Oatmeal
Since they are grown without pesticides, do organic fruits and vegetables need to be washed?…
Newsbites: Coffee consumption; impact of smoking; benefits of dietary vitamin C; “healthy” label to be redefined;
Habitual Coffee Consumption Associated with Health Benefits A study that followed nearly 400,000 middle-aged individuals…
STAT+: Northwest Bio study of cancer vaccine still falls short
Northwest Biotherapeutics tried again, but its experimental treatment for brain cancer still falls short. Last…
mRNA revolutionized the race for a Covid-19 vaccine. Could cancer be next?
This story has been adapted from the STAT Report “The future of messenger RNA: Covid-19…
STAT+: Thrive founders launch new blood testing startup to spot when cancer returns
Among the many anxiety-inducing issues faced by cancer patients is the question of whether the…
White House science adviser Alondra Nelson on the midterms, the cancer moonshot, and a book in the works
Science, according to President Joe Biden’s deputy science adviser Alondra Nelson, is more bipartisan than…
STAT+: Immunogen wins FDA approval for targeted medicine to treat advanced ovarian cancer
The Food and Drug Administration on Monday approved a new treatment for patients with advanced…
STAT+: She was a celebrated oncologist. Why did she hide her breast cancer until it was too late?
When Barrett Rollins walked into the bathroom of his Beacon Hill home, he was stunned…
STAT+: PACT Pharma’s personalized cancer treatments, powered by CRISPR, clear early safety hurdles
Two years ago, researchers at the University of Pennsylvania showed for the first time that…
STAT+: For its first two medicines, EQRx abandons its bold strategy to lower drug prices
Changing the way cancer drugs are priced in the U.S. is apparently even harder than…
STAT+: Clovis Oncology warns of likely bankruptcy filing following years of scandal and financial losses
Clovis Oncology, a maker of cancer drugs, warned Wednesday that it will likely file for…
STAT+: Shares of Merrimack, a dormant drugmaker, soar after cancer drug succeeds in trial
Shares of Merrimack Pharmaceuticals, a shuttered drug company with no employees or any active research…
Opinion: Californians: To keep kids healthy, oppose sales of flavored nicotine products
Californians have an opportunity on Tuesday to protect the health of their children by voting…
Here’s why we’re not prepared for the next wave of biotech innovation
The first time I remember hearing the words “biology’s century,” it was a sales pitch….
Opinion: Inconsistent clinical practices thwart wider use of personalized medicine
The promise of personalized medicine — safer and more effective treatments tailored to each individual’s…
‘Science is just rocketing forward’: A Q&A with former NIH director Francis Collins
LOS ANGELES — Francis Collins stepped down from his position as head of the National…
STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages
Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting…
STAT+: A new suite of RNA-sensing tools could help scientists target cancerous cells, and much more
Sure, you’ve heard of CRISPR. But it’s 2022. The acronym you need to know now…
Opinion: Kids with cancer deserve more than a cure
As an oncologist and a leader at a national cancer organization, I’ve watched countless families…
.jpg)
STAT+: Normunity launches with $65 million to unleash the immune system on tumors
Our best weapon against cancer may already live inside us — it just needs a…
Newsbriefs: Vitamin D; Red meat and CVD risk; Psyllium and constipation
MAJOR FINDING: Vitamin D Supplements Do Not Prevent Major Diseases Virtually every tissue in the…
Top Reasons to Avoid “Top Foods” Lists
You see them everywhere: “The ten best/worst foods for your health.” “The top five reasons…
Harvest the Bounty of Nutrients in Winter Squash
Need to add some variety to your menus this fall? “Add winter squash to your…
How Long Does Tinnitus Last?
According to the American Academy of Otolaryngology and Head and Neck Surgery, tinnitus is a…
What is a Pulse Oximeter?
If you have been to a doctor’s office or hospital in the last 30 years,…
STAT+: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries
Amid a push to widen access to medicines to poor countries, Novartis has reached an…
‘It still prevented cancers’: Experts discuss furor over colonoscopy study and dissect the nuances
On Sunday, the New England Journal of Medicine published the interim results of a landmark…
STAT+: AstraZeneca is fined by South Korea for an anticompetitive deal over a cancer drug
South Korea’s anti-trust regulator has fined AstraZeneca and a local generic drugmaker a total of…
STAT+: Merck pays $250 million to license a Moderna skin-cancer vaccine candidate
Merck on Wednesday agreed to extend an ongoing collaboration with Moderna to develop a personalized…
STAT+: Second U.S. oncology provider plans to go public
The U.S. is about to have not just one, but two, standalone publicly-traded oncology providers….
In gold-standard trial, colonoscopy fails to reduce rate of cancer deaths
For decades, gastroenterologists put colonoscopies on a pedestal. If everyone would get the screening just…
STAT+: CAR-T therapy doesn’t work in all cancer cases. Scientists are starting to figure out why
When CAR-T therapy works against blood cancer, it can work spectacularly, but cancer still returns…
To prevent unnecessary biopsies, scientists train an AI model to predict breast cancer risk from MRI scans
A biopsy that turns out to have benign results can be a relief. But in…
STAT+: The biotech scorecard for the fourth quarter: 13 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth…